1. Open Access Policy

All journals published by Academic Publishing Pte. Ltd. are under the Gold Open Access model. This means that all articles are immediately published online after a rigorous peer review process, and are universally and freely accessible without charge to users; all published materials can be shared, remixed without permission as long as they are properly cited.

Journals of Academic Publishing Pte. Ltd. publish articles under a Creative Commons license, specifically, Creative Commons Attribution 4.0 International License (CC BY 4.0) by default. The Creative Commons Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0) was once used by some journals and can also be used if requested by authors during the submission stage.

 

2. Publishing Ethics

Academic Publishing Pte. Ltd. follows the rules, regulations, and best practices set by:

· Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals from the International Committee of Medical Journal Editors (ICMJE)

· The Principles of Transparency and Best Practice in Scholarly Publishing as stipulated by the Committee on Publication Ethics (COPE)

· Directory of Open Access Journals (DOAJ)

· Open Access Scholarly Publishers Association (OASPA)

· World Association of Medical Editors (WAME)

Experiments should be carried out following the laws and regulations of the Ethics Committee affiliated with the author's institution. All studies using human or animal subjects should include an explicit statement in the Material and Methods section identifying the review and ethics committee approval for each study, if applicable. The statement will be displayed in the final publication. An Informed Consent Form should be obtained for all clinical treatment where disclosure is required regarding medical information, that includes discussion on the risks, benefits, and alternatives.

Academic Publishing Pte. Ltd. adheres to the guidelines of Ethical Oversight in COPE, and the Editor-in-Chief will oversee all the editorial process to ensure the objectivity, fairness and integrity of the academic scientific works. If human subjects are vulnerable groups, please obtain their guardian's written informed consent according to the Human & Animal Research Policy. All the peronal information will be considred to be confidential data, and it will not be used for commercial purposes.

Appeals and complaints

Academic Publishing Pte. Ltd. adopts a zero-tolerance policy concerning any misconduct and will aggressively address allegations from authors and readers. Allegations can be related to dissatisfaction with editorial decisions or the publishing process, and complaints about publishing ethics. Appeals and complainants could direct all correspondence to editorial_office@acad-pub.com. Information about the article and the specific reason for the complaint or appeal needs to be provided in detail. The Editorial Office will deal with it according to the procedure set out by COPE. An investigation team will be formed upon receipt of a complaint or appeal, and make a final decision based on conclusive evidence. Complainants will be informed of the decision and there are 14 days for them to appeal against the decision, except for decisions on appeals against editorial decisions.

 

3. Human & Animal Research

Human research

When human subjects were involved in the research, authors are required to provide proof of research ethics or ethics statement along with the submission. The committee or organization (e.g., authors’ Institutional Ethics Review Board) that approved the experiment should be identified. Detailed ethics approval information should include the name of the granting committee or organization and the approval identifiers, i.e., reference numbers. When ethics approval identifiers are not available, authors should provide written approval from the granting committee or organization as a confidential supplemental file.

Authors should follow the WMA Declaration of Helsinki when carrying out experiments and they should confirm that informed consent was obtained from all human subjects, or their guardians if the subjects are vulnerable. Study participants should be clearly informed of potential risks and benefits associated with participating in the experiment and their right to withhold or withdraw consent. Authors should also state how the informed consent statement was obtained from the study participants (i.e., oral or written).

It is the responsibility of authors to obtain informed consent for publication from study participants. If a study participant is a minor, written consent should be obtained from his/her parent(s) or legal guardian(s).

Authors must declare any restrictions on the availability and the use of human data in their work.

Authors are encouraged to follow the CARE guidelines while reporting a clinical case that involves human subjects. If the article reporting guidelines suggested by Academic Publishing Pte. Ltd. were not pertinent to your work, please look for and refer to the appropriate reporting standards as found on EQUATOR Network, which have been adopted by the field of the works or which apply to their study design.

 

Animal research

For studies reporting experiments that involve testing on regulated animals (i.e., all live vertebrates and/or higher invertebrates), authors should identify the committee or organization (e.g., authors’ Institutional Ethics Review Board) during the submitting stage of the manuscript, which should also detail ethics approval information such as the name of the granting committee or organization and the approval identifiers, i.e., reference numbers. For research conducted on non-regulated animals, a statement should be made as to why ethical approval was not required.

Authors are encouraged to follow the ARRIVE guidelines while reporting animal research. Experiments on non-human primates should be performed under the recommendations set out in the Weatherall report (The Use of Non-Human Primates in Research). The Editorial Office preserves the right to reject a manuscript against relevant ethical principles.

4. Patient Anonymity and Privacy

Without their informed consent, human subjects have a right to privacy that should not be infringed. Authors should not disclose identifying information of patients (e.g., name, initial, date of birth, contact, medical record number, hospital number, and geographical location), unless the information is essential for scientific purposes and patients (or his/her parent or guardian) provide written informed consent for publication. Authors are required to make an attempt to hide or mask any identifiable information about patients that exists in written or photographed content. If it is unable to completely avoid revealing patients’ identity in the published article, authors are obliged to explain to patients, show patients the identifying information (pictures, written descriptions, etc.), and obtain consent for publication from patients or legal representatives if the patient has died. Academic Publishing Pte. Ltd. will not consider submissions that include identifying patient information but without appropriate consent.

Authors are advised to refer to ICMJE Privacy and Confidentiality guidelines for more information about patient anonymity and privacy.

5. Data and Reproducibility

Academic Publishing Pte. Ltd. strives to implement open scientific practices and promote transparency, replicability, and credibility of scientific discoveries. The data referred to in this part are raw data, processed data, code, protocols, software, algorithms, research materials, etc.  

Data availability

Authors are encouraged to provide a data availability statement when submitting to the journals of Academic Publishing Pte. Ltd. This statement should contain the following information: what data are available, where to find them, and applicable access terms. Data available may be restricted due to privacy, legal or ethical reasons. Authors may be required to provide relevant datasets during the peer review and editorial decision-making stages to assess the scientific validity of the dataset.

Data repository

We encourage authors to preserve their data to discipline-specific, community-recognized repositories before making a submission. If there is no community repository, authors can find suitable data repositories by visiting re3data.org or FAIRsharing.org. To ensure long-term preservation of data, and easy access for researchers, authors are encouraged to select a repository that can provide stable identifiers for datasets and allow public access to datasets.

Data citation

Authors should properly cite the data they used in their article and include the persistent identifiers (DOI, accession number, etc.) of the datasets. If the datasets were previously published, both the article and the datasets should be cited.

6. Editorial Policies

Authors should read the Author Guidelines of the target journal before making a submission, and make sure that the manuscripts were written in accordance to the style and specifications of the journal’s policy.

All manuscripts submitted to Academic Publishing’s journals are subject to rigorous peer review. Prior to the peer review process, manuscripts will be screened for acceptable English, novelty and relevance to the Focus and Scope of the target journal.

Any manuscripts submitted to Academic Publishing’s journals will be treated as confidential materials. Manuscripts will not be disclosed to anyone except individuals such as editorial staff, reviewers and editors who participate in the initial screening, review, processing and preparation of the manuscript for publication (if accepted).

A manuscript would not be accepted if it has been published or is currently under consideration for publication in any other journals. Authors are required to notify the editorial team if the findings and data in their submissions have been presented at conferences.

7. Ethical Oversight

Academic Publishing Pte. Ltd. strictly adheres to the Core Practices and Ethical Oversight of COPE, Editor-in-Chief of each journal will supervise the entire publication process and ensure scientific integrity and impartiality. Articles must be published with the authorization of all the authors. Authors should adhere to the Patient Anonymity and Privacy Policy if their works involve human subjects. For vulnerable groups, written informed consent should be obtained so that the research trials could be published successfully. Any experiment that is contrary to animal welfare will likely be rejected.

All the information of authors is private, and it will be removed for the further peer review process, and it is only for normal publishing needs other than business marketing practices, and of course, must not be leaked to third parties.

8. Copyright & License

Authors retain the copyright, and they agree to make their original work completely available and free to use, copy, download, distribute, and reuse as long as the original source is properly cited.

Articles will be published under the Creative Commons Attribution 4.0 International License by default (only a small number of articles have been under CC BY-NC 4.0). The licensing information will be displayed both on the articles’ PDFs and their online abstract pages. Authors should apply for other licenses during the submission stage if preferring to another license.

According to this license (CC BY 4.0), users are free to:

· Share: copy and redistribute the material;

· Adapt: transform, reuse, remix and build upon the material;

as long as appropriate credit is given. Reuse of the published materials should not be in a way that suggest endorsement by the authors or the publisher.

For materials (such as figures, tables, and schemes) from other publications, authors should obtain permission from the original copyright holder before submitting to journals of Academic Publishing Pte. Ltd.

9. Conflict of Interest

For authors: Authors must declare any potential conflict of interest in related to the research when submitting the manuscript, including academic competition, and financial benefits. For example, authors could provide a list of recused reviewers if there is potential conflict of interest.

For editors: Editors should assess their own potential conflicts, and avoid participating in the whole article operation process when conflicts exist. An example of possible conflicts is having a working or personal relationship with any author.

For reviewers: Reviewers should avoid relationship with any author. If they feel unable to be objective (e.g., having a financial interest in the subject of the work), they must declare potential interest, and decline to review the manuscript. Reviewers have the right to recommend other reviewers, and the Editorial Office has preserved the right of acceptance.

10. Authorships

The International Committee of Medical Journal Editors (ICMJE) recommends that authorship should meet the following four criteria at the same time:

· having made substantial contributions to the conception, design, acquisition and analysis of data;

· having made intellectual contribution to writing the manuscript or revising it;

· final approval of the version to be published;

· making a commitment to take full responsibility for the work, including investigating and resolving any issues that may arise regarding the accuracy or integrity of any portion of it.

All designated authors should meet all the four criteria, and all individuals who meet all the four criteria should be identified. As for those who do not meet all four criteria, they should be acknowledged in the Acknowledgments section. False authorship is severely prohibited, and if discovered will result in rejection of the submission, or harsher penalties (e.g., not accepting any submissions from involved authors for a certain number of years).

Artificial Intelligence (AI) and AI-assisted technologies should not be listed as an author. The details on how to use AI should be declared in the cover letter, and in the Acknowledgments section when AI was used for writing assistance, or in the Materials and Methods section when AI was used for data collection, analysis, figure generation, etc.

The information of at lease one corresponding author (usually no more than two) should be provided, who is responsible for communicating with journal editors during the whole article operation process. They should respond to editorial queries during the processing and also respond to comments after publication in a timely manner.

Alteration to authorship

The Editorial Office considers the authorship list is definitive by the time the original submission is received.

Any addition, deletion or rearrangement of author names in the authorship list should be made only before the manuscript is accepted for publication. The corresponding author should provide the reasons for the change in the authorship list and the proof of written confirmation from all authors (including the existing authors, author(s) to be added and/or removed) agreeing with such change, to the Editorial Office.

The requests for authorship changes need to be approved by the Editorial Office before any changes can be made. The COPE flowcharts of authorship and contributorship will be followed to handle ethical issues regarding authorship.

Author contributions

All listed authors should have made significant contributions to the work and approved the final submitted version. For research articles, authors are required to add the Author Contributions section (not applicable to one author). It should be a short, one paragraph statement giving the individual contribution of each co-author to the reported research and the writing of the paper.

The following statement is suggested to be used “Conceptualization, XX and YY; methodology, XX; software, XX; validation, XX, YY and ZZ; formal analysis, XX; investigation, XX; resources, XX; data curation, XX; writing—original draft preparation, XX; writing—review and editing, XX; visualization, XX; supervision, XX; project administration, XX; funding acquisition, YY. All authors have read and agreed to the published version of the manuscript.”

11. Misconduct Policy

Academic misconduct affects the fairness of academic research and may mislead future research. Therefore, authors, editors, and reviewers are required to adhere to best practices in publishing ethics and avoid any forms of academic misconduct.

Plagiarism

Academic Publishing Pte. Ltd. uses Crossref Similarity Check (powered by iThenticate) for detecting plagiarism. All submissions are screened before being sent for further processing. Any plagiarism is strictly unacceptable, including self-plagiarism and duplicate publication without proper citations. If plagiarism is detected, we will follow the flowcharts of COPE for handling cases of potential plagiarism in a submitted manuscript or a published article.

 

Duplicate submission

Articles published in journals of Academic Publishing should be completely original. We do not accept articles that are simultaneously submitted to or have already been published in other journals. Partial but substantial duplication and duplication through paraphrasing are common forms of duplication submission. Detection of duplicate submissions will lead to rejection of the submission or withdrawal of the published article.

Fabrication and falsification

Fabrication and falsification are acts of misconduct that seriously affect the reputation of scholars and their institutions or funders, compromise the rigor of scientific research, and impede or misguide future related research. Fabrication refers to the fabrication of research data and results; falsification refers to the deliberate manipulation or alteration of data, research materials, processes, and equipment to achieve a desired experimental result. Academic Publishing has zero tolerance for such behaviors.

Peer review manipulation and citation manipulation

Any form of peer review manipulation should be prevented. The publisher will follow the material, How to recognize potential manipulation of the peer review process, supplied by COPE to check for such cases, and to monitor the peer review process. The identity and qualifications of reviewers will be verified and the validity of the review report will be checked to minimize peer review manipulation.

As for citation manipulation, it usually refers to excessive citations only to increase the number of citations:

Excessively citing articles of the author;

Excessively citing articles published in the target journal;

Honorarily citing articles of the Editor-in-Chief of the target journal or a well-known scholar.

Citation manipulation will be detected by the publisher, and self-citation thresholds for authors and reviewers will be set. While editors and reviewers are experts in the field and may recommend literature, they should not advise authors to cite their articles that are not relevant to or do not contribute to the author’s research.

Handling misconduct

Academic Publishing Pte. Ltd. treats potential misconduct seriously and will organize an investigation immediately upon receipt of allegations, where the guidelines for handling allegations of misconduct set by COPE will be followed. The investigation group will be led by the Editor-in-Chief, who will make the final decision based on clear evidence. Authors are responsible for providing necessary information and responding to queries during the investigation. Where misconduct is verified, the authors and their institutions will be informed. Authors’ institutions may also be requested to cooperate with the publisher in this process.

Some possible responses to misconduct include:

· Rejecting the submission directly;

· Issuing an erratum/correction;

· Retracting a published article;

· Not accepting submissions from the author(s) for a period of time;

· Not allowed to serve as an editor or reviewer.

Any appeal or complaint could be made to the Editorioal Office with appropriate response. Please refer to the Appeals and Complaints in the Publishing Ethics policy.

12. Correction, Retraction & Withdrawal Policy

Correction

Editors, authors, and readers, whoever find that a correction is required in the publication, should feel free to contact editorial_office@acad-pub.com. Please clearly state the content that needs to be changed. Please also send the article title, DOI, and page number to us. Upon approval by the Editorial Office, a corrreciton will be published in the current issue. Note that a correction should not affect the scientific results and integrity of the experiments.

 

Retraction policy

Academic Publishing Pte. Ltd. considers retracting the publication if there is clear evidence of unreliable results, redundant publication, plagiarism, infringement of copyright, evident calculation errors, unethical research, etc.

Academic Publishing Pte. Ltd. abides by the Retraction Guidelines of the Committee on Publication Ethics (COPE). Articles will be retracted as soon as possible to minimize the negative effect of the article on other researchers’ work. Instead of removing from the journal website, retracted articles will be marked with “Retracted”, accompanied by retraction notices being issued by the publisher. Reasons for the retraction and who initiated the retraction action should be included in the retraction notice. Please note that APCs will not be refunded due to the retraction of an article.

 

Withdrawal policy

Academic Publishing Pte. Ltd. does not support the withdrawal of publication unless that it may be suspected of academic misconduct. If the author can provide a reasonable application to the Editorial Office after it has been accepted (but not yet published), and the Editorial Office agrees to the request, a processing fee of USD 200 is chargeable upon withdrawal. Withdrawn manuscripts will be deleted from the OJS system and all authors will receive an official notification of withdrawal, which means the withdrawal action is finished.

13. Preprints

Academic Publishing Pte. Ltd. recognizes the benefits of preprints to authors and the research community, and therefore accepts submissions that are shared via preprint platforms. The premise is that these submissions have not been peer-reviewed.

Authors should notify the editors of a preprint posting and provide any corresponding DOIs or accession numbers and licensing terms during the submission stage. Authors should not post any revised versions of the article on a preprint server while undergoing the peer review process.

When the article has been published, Academic Publishing Pte. Ltd. encourages authors to update the preprint with the DOI and the link to the article on the journal website.

14. Article Processing Charges (APCs)

Academic Publishing Pte. Ltd. publishes all its journals in Gold Open Access format and there is no charge to readers. In order to defray our editorial and production costs, authors of accepted articles are required to pay an article processing charge (APC), which will not be affected by article length. The charges will come from authors' institutes or research funding bodies. Authors will not be levied any other fees other than APCs.

Waiver and discount policy

Academic Publishing Pte. Ltd. develops a waiver and discount policy for authors from low-income countries. Authors who would like to apply for waivers and discounts should contact editorial_office@acad-pub.com before submitting to the target journal. The publisher reserves the right to approve or reject a waiver/discount application. The editorial decision making will not be affected by APCs or the status of waivers/discounts.

15. Advertisement Policy

Academic Publishing Pte. Ltd. accepts advertising. All advertisements are subject to approval by the publisher. Advertising applications, inquiries, appeals, or complaints should be addressed to editorial_office@acad-pub.com with details. Some basic rules of our advertising policies are:

1. Advertisements should be clearly distinguished from the editorial content.

2. Advertisements must not influence editorial decisions and editorial content.

3. All advertisements and pharmaceutical products must comply with the relevant laws, regulations, and industry norms of the country in which they are published.

4. The proprietary name of pharmaceutical products must be accompanied by the chemical, generic, or official name; the quantities of all active substances must be stated, as well as the recommended dosage.

5. Advertisers and products or services offered should be clearly displayed.

6. Advertisements must not contain deceptive or misleading information or obscene or discriminatory information.

7. The publisher does not endorse the products or services mentioned in the advertisements and shall not be liable for any harm caused by them.

8. Advertising space is at the discretion of the publisher and no fixed position can be guaranteed.

9. The publisher reserves the right to remove any advertisement if the Editor(s)-in-Chief or journal editors request its removal.

16. Section Collection Policy

Some journals of Academic Publishing Pte. Ltd. run a Section Collection program, and a section collection is a research collection of some particular fields. Scholars in this section field will act as Guest Editors and drive this section. Guest Editors should try their best to call for excellent submissions for the section.

Scholars could submit proposals on a section collection, and the Editor-in-Chief or senior editors will evaluate its scope and interest. It should be noted that a hot area may be a good proposal for more attraction and visibility. The Editorial Office also prepares some topics and invites scholars in the section discipline to be Guest Editors.

All the submissions must comply with the journal’s editorial and publishing ethics, and they will be processed according to the peer review process of each journal. Guest Editors could not act as reviewers at any stage, and the Editor-in-Chief takes charge of the whole editorial process for objectivity and fairness.

17. Archiving

· All the publications will be archived by the PKP Preservation Network for long-term electronic preservation.

· Authors are encouraged to self-archive the final version of their published articles into institutional repositories (such as those listed in the Directory of Open Access Repositories).

· Authors are also encouraged to use the final PDF version published on the website of Academic Publishing.

18. Units of Measurement

All articles published by Academic Publishing Pte. Ltd. should follow the standards of the International System of Units (SI) for measurements and units. The format of numbers and units should be consistent throughout the article.

19. Disclaimer

Academic Publishing Pte. Ltd. is not liable for the statements, perspectives, and opinions contained in the published articles. The publisher disclaims responsibility for any injury to people or property resulting from any ideas or products referred to in the articles or advertisements.

20. Privacy Statement

Academic Publishing Pte. Ltd. respects your privacy and will endeavor to handle and protect your personal information appropriately.

Academic Publishing Pte. Ltd. publishes open access journals. Therefore, if you visit our website as a reader, there is no need to register for an account. However, your access history, including your IP address, pages visited, and time of day, will be automatically collected, which may be used for us to analyze web pages, resolve access issues, and optimize site performance.

If you register as an author, or we help you register a reviewer or editor account, we will collect your personal information: name, organization, email address, etc. We encourage users, especially reviewers, to provide more detailed information such as phone number, fax number, title, ORCID ID, and research interests, so as to identify you. For authors, your information will be used for article review and publication, and processing of the payment of APCs. Some of the authors’ information will also be delivered to third party databases for the purpose of sharing their published articles. For editors and reviewers, we will contact you and invite you to screen and review submissions. Editors may receive emails from us about developments in the journal.

We do not disclose, sell, or lease your personal information to any third party without your permission. We strive to protect your information we collect from unauthorized access, disclosure, damage, or loss by adopting appropriate physical administration and technical measures.

You have the right to access your personal data and ask us to update or delete your information from our system.

If you have any questions about our privacy policy or your personal account, please send an email to editorial_office@acad-pub.com.

21. Author Guidelines

1) Submission preparation

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.

The submission has not been previously published, nor is it under consideration by other journals (or an explanation has been provided in Comments to the Editor).

The submission file is in Microsoft Word or LaTex file.

Where available, URLs/DOIs for the references have been provided.

The text adheres to the stylistic and bibliographic requirements outlined in each journal’s Author Guidelines.

If submitting to a peer-reviewed section of the journal, the instructions in each journal’s Ensuring a Blind Review have been followed.

 

2) Author guidelines

Please carefully check that your manuscript has been prepared following the step-by-step instructions provided before being submitted to the target journal’s online submission system. Please follow the author guidelines and prepare your manuscript according to the journal’s Template.

 

Ensure that the article format meets the article structure requirements of the target journal. Please prepare a cover letter describing the innovation, significance, and essence of this research. Also, submit an approved conflict of interest statement with the signatures of all authors. Please confirm the authorship according to the Authorship Policy. If ethical approval is necessary, please also submit the appropriate supporting documents.

 

Academic Publishing Pte. Ltd. asks authors to declare the responsibilities of each author in the Author Contributions section if the article is a research article. There are no specific requirements for other article types. If some organizations have funded this work, please list the sources of financial support.

 

For contributors that do not justify authorship, please thank them in the Acknowledgements section.

 

3) Peer review process

Manuscripts submitted will undergo a rigorous double-blind peer review process. Reviewers should make an evaluation and provide recommendations to ensure the scientific quality of manuscripts is on a par with our standards. Reviewers are requested to provide authentic, constructive comments for the assigned manuscript on time.

Primarily check

After submission, a manuscript will be initially screened by the editorial staff for originality. Only manuscripts that pass the originality screen are sent to the Editor-in-Chief for initial review.

The Editor-in-Chief will check the manuscript, including its innovativeness, and whether the research matches the scope of this journal. Then, a senior editor will assign it to at least two independent expert peer reviewers. Authors could recommend reviewers or provide an avoidance list, but the publisher reserves the right to adopt them.

Peer review

Once agreeing to review the assigned manuscript, reviewers will get full access to the entire manuscript (at least 3 weeks are allowed). Both authors and reviewers are kept confidential from each other. Therefore, assigned manuscripts do not contain any identifying information, including names, affiliations, funding, and acknowledgements. All recommended decisions are collected by the senior editor, and the Editor-in-Chief will make a final decision.

Editorial decision

· Accept: Manuscripts will undergo the copyediting and proofreading stages without revision.

· Minor revision: Manuscripts only need minor revisions before being accepted. There is no need for another peer review process, and after the revision (usually 2 weeks), the Editorial Office will accept it.

· Major revision: Manuscripts need more revision during 4 weeks. They will be assigned to the same or new reviewers for further review until a new review decision.

· Reject: Manuscripts are rejected and no further consideration will be made.

Appeal against editorial decisions

Authors can appeal against editorial decisions by sending an email to editorial_office@acad-pub.com within 4 weeks of receiving the notification. Information about the article, the reason for the complaint, point-by-point responses to the reviewers' comments, etc., need to be provided in detail. An investigation team will be formed, and the Editor-in-Chief will make a decision based on conclusive evidence. The decision on the appeal is final and no further considerations will be made.

Confidentiality

Manuscripts under peer review should be strictly confidential. Reviewers could be experts in the field of this journal. Candidates for reviewers should declare any possible conflicts to ensure that objective evaluation and comments will be made. Reviewers must not share any details or discuss the research with others. The Editorial Office must not disclose any information about manuscripts to anyone except reviewers and co-authors.

4) Production

Once a manuscript is accepted, the editorial staff will organize the production of the paper, which includes copyediting, layout editing, proofreading, and final production.

The whole submission, peer-review, and editorial processes are maintained through the OJS system.

All the published articles will be archived on the website of each journal, and if you need more archiving policies, please see the Archiving policy of your target journal.